In AD, reduced levels of BDNF and impaired signaling through its receptor, tropomyosin-related kinase B (TrkB), are particularly evident in the hippocampus and are strongly associated with cognitive decline.56 The gene discussed is NTRK2; the disease is Alzheimer disease.